Oppenheimer Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
Oppenheimer Sticks to Its Buy Rating for Abbott Laboratories (ABT)
Market Falls Wednesday, but Googles Chip Impresses | WST
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth?
Monday Market Falls, Chinese Stocks Climb, Indices Rebalance | Live Stock
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness
The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA
Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.
University of Nebraska Wins the Abbott and Big Ten Conference's Nationwide 'We Give Blood Drive' Competition, Receives $1 Million Grant From Abbott
Weekly Buzz: Now THOSE are records!!
Index Records are BACK for Friday Market While Unemployment Climbs | Live Stock
Wells Fargo's 'Core' List: GOOGL, DIS, HD, WMT, and More!
Peering Into Abbott Laboratories's Recent Short Interest
Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note
Thursday Indexes Pull back From Records While Bitcoin Sets New Ones | Wall Street Today
100k Bitcoin! Market Pulls Back After Records | Live Stock
Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up
S&P and Nasdaq on Track for Third Record Close This Week | Live Stock
Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock